In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We've got lots ...

In a report released on January 21, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research ...

The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...